These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 33096451

  • 1. Trans-chalcone induces death by autophagy mediated by p53 up-regulation and β-catenin down-regulation on human hepatocellular carcinoma HuH7.5 cell line.
    Siqueira EDS, Concato VM, Tomiotto-Pellissier F, Silva TF, Bortoleti BTDS, Gonçalves MD, Costa IN, Junior WAV, Pavanelli WR, Panis C, Mantovani MS, Miranda-Sapla MM, Conchon-Costa I.
    Phytomedicine; 2021 Jan; 80():153373. PubMed ID: 33096451
    [Abstract] [Full Text] [Related]

  • 2. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H, Chen F, Zhang L, Zhou Q, Gui S, Wang Y.
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [Abstract] [Full Text] [Related]

  • 3. Phenethyl isothiocyanate inhibits the carcinogenic properties of hepatocellular carcinoma Huh7.5.1 cells by activating MAPK/PI3K-Akt/p53 signaling pathways.
    Du J, Zhang Y, Chen J, Jin L, Pan L, Lei P, Lin S.
    PeerJ; 2024 Jul; 12():e17532. PubMed ID: 38873643
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53/DRAM-mediated autophagy in human hepatocellular carcinoma.
    Liu X, Liu J.
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):488-497. PubMed ID: 32013613
    [Abstract] [Full Text] [Related]

  • 5. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
    Wu G, Lin N, Xu L, Liu B, Feitelson MA.
    BMC Cancer; 2013 Mar 28; 13():167. PubMed ID: 23537372
    [Abstract] [Full Text] [Related]

  • 6. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W, Chua MS, Grepper S, So S.
    Int J Cancer; 2010 May 15; 126(10):2426-36. PubMed ID: 19662654
    [Abstract] [Full Text] [Related]

  • 7. Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosis.
    Jaganathan R, Ravinayagam V, Panchanadham S, Palanivelu S.
    BMC Complement Altern Med; 2013 Nov 21; 13():323. PubMed ID: 24256980
    [Abstract] [Full Text] [Related]

  • 8. Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma.
    Yang X, Xie J, Liu X, Li Z, Fang K, Zhang L, Han M, Zhang Z, Gong Z, Lin X, Shi X, Gao H, Lu K.
    Cell Biochem Funct; 2019 Apr 21; 37(3):128-138. PubMed ID: 30883849
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
    Zhang B, Yin X, Sui S.
    Oncol Rep; 2018 Nov 21; 40(5):2758-2765. PubMed ID: 30132535
    [Abstract] [Full Text] [Related]

  • 10. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B, Wang X, Deng J, Zheng H, Liu W, Chen S, Tian J, Wang F.
    Cancer Lett; 2019 Sep 10; 459():50-58. PubMed ID: 31163195
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of tetrahydropyridinol derivatives on β-catenin signaling and invasion in human hepatocellular and breast carcinoma cells.
    Yadunandam AK, Yoon JS, Jeong YT, Kim WY, Lee SY, Kim GD.
    Int J Mol Med; 2015 Aug 10; 36(2):577-87. PubMed ID: 26059838
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
    Hawash MM, Kahraman DC, Eren F, Cetin Atalay R, Baytas SN.
    Eur J Med Chem; 2017 Mar 31; 129():12-26. PubMed ID: 28219046
    [Abstract] [Full Text] [Related]

  • 13. Modulatory Effects of Chalcone Thio-Derivatives on NF-κB and STAT3 Signaling Pathways in Hepatocellular Carcinoma Cells: A Study on Selected Active Compounds.
    Papierska K, Judasz E, Tonińska W, Kubicki M, Krajka-Kuźniak V.
    Int J Mol Sci; 2024 Oct 05; 25(19):. PubMed ID: 39409068
    [Abstract] [Full Text] [Related]

  • 14. Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro.
    Bi L, Yan X, Chen W, Gao J, Qian L, Qiu S.
    Integr Cancer Ther; 2016 Jun 05; 15(2):226-36. PubMed ID: 27179035
    [Abstract] [Full Text] [Related]

  • 15. Induction of cell cycle arrest and apoptosis by tomentosin in hepatocellular carcinoma HepG2 and Huh7 cells.
    Yu SH, Lee CM, Ha SH, Lee J, Jang KY, Park SH.
    Hum Exp Toxicol; 2021 Feb 05; 40(2):231-244. PubMed ID: 32787465
    [Abstract] [Full Text] [Related]

  • 16. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC, Meng FD, Qu K, Wang ZX, Wu QF, Zhang LQ, Pang Q, Liu C.
    Acta Pharmacol Sin; 2015 Feb 05; 36(2):241-51. PubMed ID: 25557114
    [Abstract] [Full Text] [Related]

  • 17. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C, Li J.
    Cancer Lett; 2016 Jun 28; 376(1):10-21. PubMed ID: 26975630
    [Abstract] [Full Text] [Related]

  • 18. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ, Zuo GW, Feng ZQ, Zhao LC, Luo L, You ZM, Li DY, Xia J, Li J, Chen DL.
    Asian Pac J Cancer Prev; 2014 Jun 28; 15(18):7849-55. PubMed ID: 25292076
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.
    Gabata R, Harada K, Mizutani Y, Ouchi H, Yoshimura K, Sato Y, Kitao A, Kimura K, Kouji H, Miyashita T, Tajima H, Ohta T.
    Anticancer Res; 2020 Sep 28; 40(9):5211-5219. PubMed ID: 32878809
    [Abstract] [Full Text] [Related]

  • 20. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.